Harrow Health, Inc.HROWNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank46
5Y CAGR-38.4%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-38.4%/yr
Long-term compound
Percentile
P46
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.72% |
| Q3 2025 | 29.26% |
| Q2 2025 | 201.58% |
| Q1 2025 | -187.08% |
| Q4 2024 | 876.46% |
| Q3 2024 | -13.66% |
| Q2 2024 | 122.08% |
| Q1 2024 | -42.11% |
| Q4 2023 | -379.53% |
| Q3 2023 | -25.85% |
| Q2 2023 | 94.38% |
| Q1 2023 | 168.05% |
| Q4 2022 | -1791.49% |
| Q3 2022 | -105.56% |
| Q2 2022 | -19.56% |
| Q1 2022 | 219.72% |
| Q4 2021 | 52.78% |
| Q3 2021 | -189.16% |
| Q2 2021 | 42.92% |
| Q1 2021 | 11.08% |
| Q4 2020 | 64.43% |
| Q3 2020 | 149.75% |
| Q2 2020 | -411.15% |
| Q1 2020 | -167.82% |
| Q4 2019 | 121.06% |
| Q3 2019 | -473.40% |
| Q2 2019 | -37.95% |
| Q1 2019 | 74.29% |
| Q4 2018 | -233.28% |
| Q3 2018 | -4.01% |
| Q2 2018 | 64.96% |
| Q1 2018 | 17.20% |
| Q4 2017 | 22.18% |
| Q3 2017 | 8.39% |
| Q2 2017 | 28.69% |
| Q1 2017 | -20.61% |
| Q4 2016 | 23.94% |
| Q3 2016 | -15.07% |
| Q2 2016 | -6.77% |
| Q1 2016 | 20.04% |